siRNA treatment reduces triglycerides in individuals along with unusual ailment

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran lowered triglyceride amounts by 80% and decreased the risk of pancreatitis in people with relentless chylomicronemia, along with or even without a genetic prognosis.